DE69637002D1 - Verwendung des epidermalen Wachstumsfaktors zur Steigerung der Gewichtszunahme beim Tier - Google Patents

Verwendung des epidermalen Wachstumsfaktors zur Steigerung der Gewichtszunahme beim Tier

Info

Publication number
DE69637002D1
DE69637002D1 DE69637002T DE69637002T DE69637002D1 DE 69637002 D1 DE69637002 D1 DE 69637002D1 DE 69637002 T DE69637002 T DE 69637002T DE 69637002 T DE69637002 T DE 69637002T DE 69637002 D1 DE69637002 D1 DE 69637002D1
Authority
DE
Germany
Prior art keywords
animal
growth factor
weight gain
epidermal growth
egf
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69637002T
Other languages
English (en)
Other versions
DE69637002T2 (de
Inventor
Andre G Buret
D Grant Gall
James A Hardin
Merle E Olson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University Technologies International Inc
Original Assignee
University Technologies International Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University Technologies International Inc filed Critical University Technologies International Inc
Publication of DE69637002D1 publication Critical patent/DE69637002D1/de
Application granted granted Critical
Publication of DE69637002T2 publication Critical patent/DE69637002T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A23K20/147—Polymeric derivatives, e.g. peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/168—Steroids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/184—Hormones
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1808—Epidermal growth factor [EGF] urogastrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Animal Husbandry (AREA)
  • Food Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Fodder In General (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69637002T 1995-05-10 1996-05-09 Verwendung des epidermalen Wachstumsfaktors zur Steigerung der Gewichtszunahme beim Tier Expired - Fee Related DE69637002T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/438,901 US5753622A (en) 1995-05-10 1995-05-10 Use of epidermal growth factor as a gastrointestinal therapeutic agent
US438901 1995-05-10

Publications (2)

Publication Number Publication Date
DE69637002D1 true DE69637002D1 (de) 2007-05-10
DE69637002T2 DE69637002T2 (de) 2007-08-16

Family

ID=23742496

Family Applications (3)

Application Number Title Priority Date Filing Date
DE69614377T Expired - Fee Related DE69614377T2 (de) 1995-05-10 1996-05-09 Verwendung des epidermalen wachstumsfaktors als magen-darm therapeutikum
DE69637002T Expired - Fee Related DE69637002T2 (de) 1995-05-10 1996-05-09 Verwendung des epidermalen Wachstumsfaktors zur Steigerung der Gewichtszunahme beim Tier
DE69633583T Expired - Fee Related DE69633583T2 (de) 1995-05-10 1996-05-09 Verwendung des epidermalen Wachstumsfaktors als Magen-Darm Therapeutikum

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE69614377T Expired - Fee Related DE69614377T2 (de) 1995-05-10 1996-05-09 Verwendung des epidermalen wachstumsfaktors als magen-darm therapeutikum

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE69633583T Expired - Fee Related DE69633583T2 (de) 1995-05-10 1996-05-09 Verwendung des epidermalen Wachstumsfaktors als Magen-Darm Therapeutikum

Country Status (13)

Country Link
US (2) US5753622A (de)
EP (3) EP0824357B1 (de)
JP (1) JP3549541B2 (de)
AT (3) ATE357927T1 (de)
AU (1) AU704675B2 (de)
CA (2) CA2220434C (de)
DE (3) DE69614377T2 (de)
DK (3) DK1479394T3 (de)
ES (2) ES2285320T3 (de)
HK (1) HK1072894A1 (de)
NZ (2) NZ307134A (de)
PT (1) PT1479394E (de)
WO (1) WO1996035445A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5753622A (en) * 1995-05-10 1998-05-19 University Technologies International, Inc. Use of epidermal growth factor as a gastrointestinal therapeutic agent
US5929051A (en) * 1998-05-13 1999-07-27 Carrington Laboratories, Inc. Aloe pectins
US7022683B1 (en) * 1998-05-13 2006-04-04 Carrington Laboratories, Inc. Pharmacological compositions comprising pectins having high molecular weights and low degrees of methoxylation
US6313103B1 (en) 1998-05-13 2001-11-06 Carrington Laboratories, Inc. Pectic substance as a growth factor stabilizer
US20060014684A1 (en) * 2000-03-03 2006-01-19 University Technologies International Inc. Novel uses of EGF
US7494669B2 (en) 2001-02-28 2009-02-24 Carrington Laboratories, Inc. Delivery of physiological agents with in-situ gels comprising anionic polysaccharides
WO2002095029A2 (en) * 2001-05-18 2002-11-28 Her Majesty The Queen In Right Of Canada As Represented By The Minister Of Agriculture And Agri-Food Canada Nucleic acid and protein sequences of bovine epidermal growth factor
JP2005507919A (ja) * 2001-10-26 2005-03-24 ユニヴァーシティ・テクノロジーズ・インターナショナル・インコーポレーテッド 泌尿生殖器経路の病原感染を阻害するためのｅｇｆの使用
CA2427190A1 (en) * 2002-04-30 2003-10-30 Alberta Research Council Inc. Production of recombinant epidermal growth factor in plants
DE60319822T2 (de) * 2002-06-19 2009-06-04 Actogenix Nv Verfahren und mittel zur erhöhung der darmabsorption
US20110245171A1 (en) * 2004-09-30 2011-10-06 Hardin James A Rehydration compositions comprising epidermal growth factor (egf)
US8703769B2 (en) * 2005-07-15 2014-04-22 The University Of North Carolina At Chapel Hill Use of EGFR inhibitors to prevent or treat obesity
WO2007063075A1 (en) 2005-11-29 2007-06-07 Actogenix Nv Induction of mucosal tolerance to antigens
CA3037889C (en) 2007-01-25 2022-09-13 Intrexon Actobiotics Nv Treatment of immune disease by mucosal delivery of antigens
WO2010042821A1 (en) * 2008-10-10 2010-04-15 Nationwide Children's Hospital Method of treating necrotizing enterocolitis using heparin binding epidermal growth factor
CN102696887B (zh) * 2012-06-20 2013-07-31 湖南海谷生物技术有限公司 一种具有营养保健促生长功能的饲料活性蛋粉及其生产方法
US11241480B2 (en) * 2017-01-26 2022-02-08 Washington University Methods for modulation of dietary and microbial exposure with compositions comprising an EGFR ligand
CN113813369B (zh) * 2021-11-09 2023-09-22 浙江省农业科学院 用于预防/治疗仔猪肠道损伤的egf/mmt复合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8409960D0 (en) * 1984-04-17 1984-05-31 Searle & Co Therapeutic method
AU620797B2 (en) * 1986-12-11 1992-02-27 British Technology Group Limited Improvements in or relating to the use of epidermal growth factor
ATE161181T1 (de) 1992-07-06 1998-01-15 Nestle Sa Lactobacillus acidophilus enthaltende antigastritis-mittel
US5753622A (en) * 1995-05-10 1998-05-19 University Technologies International, Inc. Use of epidermal growth factor as a gastrointestinal therapeutic agent

Also Published As

Publication number Publication date
EP0824357B1 (de) 2001-08-08
CA2220434A1 (en) 1996-11-14
DK1092437T3 (da) 2005-01-31
JPH11505528A (ja) 1999-05-21
EP1479394B1 (de) 2007-03-28
US5753622A (en) 1998-05-19
DE69633583D1 (de) 2004-11-11
JP3549541B2 (ja) 2004-08-04
EP1479394A1 (de) 2004-11-24
CA2220434C (en) 2005-02-22
ATE357927T1 (de) 2007-04-15
HK1072894A1 (en) 2005-09-16
DE69633583T2 (de) 2006-02-23
AU704675B2 (en) 1999-04-29
DE69614377T2 (de) 2002-05-23
EP1092437B1 (de) 2004-10-06
NZ307134A (en) 2000-02-28
EP0824357A1 (de) 1998-02-25
ES2226681T3 (es) 2005-04-01
AU5641196A (en) 1996-11-29
DE69614377D1 (de) 2001-09-13
WO1996035445A1 (en) 1996-11-14
ATE278415T1 (de) 2004-10-15
EP1092437A1 (de) 2001-04-18
CA2492724A1 (en) 1996-11-14
ES2285320T3 (es) 2007-11-16
NZ501482A (en) 2004-12-24
PT1479394E (pt) 2007-04-30
DK0824357T3 (da) 2001-10-08
CA2492724C (en) 2010-08-03
US6656907B1 (en) 2003-12-02
DK1479394T3 (da) 2007-06-11
DE69637002T2 (de) 2007-08-16
ATE203912T1 (de) 2001-08-15

Similar Documents

Publication Publication Date Title
HK1072894A1 (en) The use of epidermal growth factor (egf) for increasing weight gain in an animal
GR3006124T3 (de)
SE8703696D0 (sv) Antioxidationsmedelskomposition och forfarande for framstellning derav
ATE301937T1 (de) Verfahren zur herstellung eines produkts zur erhöhung der immunantwort bei haustieren mit verwendung einer kombination von antioxidantien
DE58906691D1 (de) Aromatische Carbonsäurederivate und ihre Verwendung zur Bekämpfung unerwünschten Pflanzenwuchses.
AU1277688A (en) Sustained release compositions for parenteral administration and their use
ATE283241T1 (de) Mittel zur herstellung von aquarien- und gartenteichwasser und verwendung davon
DE3681144D1 (de) Verwendung biologisch aktiver copolymere zur herstellung eines arzneimittels zur stimulierung des wachstums von tieren.
ATE24505T1 (de) Cyclohexan-1,3-dionderivate, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung unerwuenschten pflanzenwuchses.
ATE47274T1 (de) Tierstreu sowie verfahren zur herstellung derselben.
ATE45859T1 (de) Geschmackszusammensetzung, verwendung und herstellung davon.
ATE8049T1 (de) 1,3-dioxan-5-yl-alkyltriazole, ihre herstellung, ihre verwendung zur regulierung des pflanzenwachstums und mittel dafuer.
DE68905657D1 (de) Verwendung von arginin-aspartat zur herstellung eines arzneimittels zur behandlung gewisser gedaechtnisstoerungen.
ATE83480T1 (de) Cyclisches peptid, seine herstellung und seine verwendung zur behandlung von cardiovasculaeren stoerungen.
ATE59392T1 (de) Saccharose-tricarbonsaeure und ihre derivate, verfahren zur herstellung von saccharosetricarbons|ure und ihren salzen und ihre verwendung.
DE3582484D1 (de) Verfahren zur herstellung von benzylierten phenolen, dibenzylphenolverbindungen und die verwendung solcher phenole als antioxidantien.
JPS5729270A (en) Preparation of nonheat-coagulable egg white
DE59002155D1 (de) Verfahren zur herstellung von alkoholfreien getraenken, enthaltend fermentativ gewonnene milchsaeure.
ATE84673T1 (de) Verfahren zur herstellung von fliessfaehigen milchsaeure-zusammensetzungen.
DE3766546D1 (de) Fluoralkylsubstituierte chinolinderivate. ihre herstellung sowie verwendung zur bekaempfung unerwuenschten pflanzenwachstums.
JPS6439981A (en) Natural antiseptic for raw sake
DE3783466T2 (de) Vitamin u und verfahren zur behandlung von tieren mit vitamin u.
ATE55909T1 (de) Mittel zur verhinderung, verminderung oder verzoegerung der eiweissfaeulnis im verdauungstrakt von mensch oder tier und verfahren zur herstellung eines solchen mittels.
HUT51455A (en) Compositions regulating the growth of plants containing as active substance derivatives of indole and naphtile carbonic acid and process for production of the active substances
ATE43595T1 (de) Derivate des 2-furylbutyrolactons, ihre herstellung, diese enthaltende zusammensetzungen und ihre verwendung zur veraenderung des immunsystems bei saeugetieren.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee